MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-03-06 (finanzen.ch)
Cosmo share still falls deep into the minus: growth thanks to key products in 2024 | 06.03.25 |
The specialty pharmaceutical company Cosmo recorded a leap in profits in 2024.
Read more2025-02-19 (investire.biz)
US quarterly: it is the day of analog devices and Carvana |
Let's see how the US quarterly of yesterday and the expectations for the companies that will publish the results have gone
Read more2025-02-18 (fxstreet.cz)
Company results this week: Kofola, Photon Energy, Walmart, Alibaba, .. | .cz
The result season continues. In the Czech Republic on Monday, Kofola's management will announce its results and Photon Energy energy company on Wednesday. In Germany from the DAX Index this week, the German car manufacturer Mercedes-Benz and aircraft manufacturer and air technology Airbus will be reported. In the UK, for example, Rio Tinto and HSBC are announced. In the US this week, 44 companies from the S&P 500 index will be reported. The retail chain of Walmart and Medtronic healthcare facilities will be published. In China, the technology giant Alibaba and the largest BAIDA internet search engine announce its economic results.
Read more2024-10-24 (bmj.com)
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort
Background Unruptured intracranial aneurysm treatment aims to reduce the risk of aneurysm rupture and bleeding, relieves symptoms and improve the quality of life for patients. This study aimed to assess the safety and efficacy of Pipeline Embolization Device( PED, Covidien/Medtronic, Irvine, CA)
Read more2024-10-07 (secardiologia.es)
SHAM-PVI Study: Pulmonary Vein Isolation Versus Sham Intervention in Symptomatic AF
This study evaluates whether the benefit of pulmonary vein ablation in the treatment of atrial fibrillation is due to a placebo effect.
Read more2024-09-02 (jamanetwork.com)
Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation
This randomized clinical trial assesses the effect of pulmonary vein isolation vs a sham procedure on atrial fibrillation burden at 6 months in patients
Read more2024-07-19 (medicaldevice-network.com)
Medtronic recalls endotracheal tube products
Medtronic still dominates the endotracheal tube market, but the incident is expected to have a noticeable effect on future sales.
Read more2024-06-05 (tipranks.com)
Medtronic Executive Retirement Signals Leadership Change
The latest update is out from Medtronic (MDT). Rob ten Hoedt, a high-ranking executive at Medtronic plc, has announced his retirement, set to take effect on June 28...
Read more2024-05-05 (scientistlive.com)
Sustainability: a life sciences perspective
Driving sustainability in life sciences industry through digital technologies
Read more2024-02-29 (cardiovascularnews.com)
TCT 2024: Two-year SPYRAL HTN-ON MED show “consistent” effect of renal denervation
Medtronic has announced new, long-term data from the SPYRAL HTN-ON MED clinical trial that showed subjects who underwent radiofrequency renal denervation with the Symplicity Spyral renal denervation system had significantly greater reductions in 24-hr ambulatory systolic blood pressure, and
Read more2024-02-16 (yahoo.com)
Medtronic names Raman Venkatesh as first chief sustainability officer
Venkatesh will be responsible for leading the development and execution of Medtronic’s environmental sustainability strategy.
Read more2024-02-14 (mddionline.com)
Medtronic Doubles Down on Sustainability Efforts
The Dublin-based company has tapped Raman Venkatesh to be its first VP & Chief Sustainability Officer.
Read more